IceCure Medical

IceCure’s ProSense Installation in India is the First to Offer Cryoablation for the Treatment of Breast Cancer in the Country

by

Latest system installation in IceCure’s global commercial rollout of ProSense CAESAREA, Israel, May 31, 2023 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that ProSense was recently installed and inaugurated at … Read more

IceCure to Report First Quarter 2023 Financial & Operational Results on May 22, 2023

by

CAESAREA, Israel, May 15, 2023 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it will release its financial and operational results for the three months ended March 31, 2023 with … Read more